Financial Summary (All financials)
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
Revenues | 11.3 | 15.1 | 0.6 | 0.6 | 0.8 | 0.3 | 0.0 | 0.0 |
Revenue growth | -25.1% | 2385.8% | 6.6% | -27.6% | 169.4% | | | -100.0% |
Cost of goods sold | 5.0 | 5.8 | 0.2 | 0.3 | 0.4 | 0.1 | 0.0 | 0.0 |
Gross profit | 6.3 | 9.3 | 0.4 | 0.2 | 0.4 | 0.2 | 0.0 | 0.0 |
Gross margin | 55.4% | 61.7% | 73.0% | 41.4% | 45.2% | 57.2% | | |
Selling, general and administrative | 15.2 | 22.1 | 19.3 | 22.8 | 18.0 | 19.9 | 14.6 | 13,658.8 |
Research and development | 3.5 | 3.1 | 5.7 | 5.4 | 5.2 | 8.1 | 11.0 | 11,075.5 |
General and administrative | 10.5 | 17.2 | 14.0 | | | | | |
EBITA | -10.8 | -14.2 | -24.3 | -28.0 | -22.8 | -27.9 | -25.6 | -24,734.3 |
EBITA margin | -95.6% | -94.2% | -4010.4% | -4915.3% | -2897.8% | -9543.4% | | |
Amortization of intangibles | 1.7 | 1.7 | 0.2 | 0.1 | | | | |
EBIT | -12.5 | -15.9 | -24.5 | -28.1 | -22.8 | -27.9 | -25.6 | -24,734.3 |
EBIT margin | -110.2% | -105.3% | -4043.0% | -4929.1% | -2897.8% | -9543.4% | | |
Pre-tax income | -21.8 | -75.1 | -38.7 | -32.8 | -23.4 | -25.5 | -26.1 | -25,780.7 |
Income taxes | -0.2 | -0.9 | -3.4 | -2.3 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.8% | 1.2% | 8.9% | 7.1% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -21.6 | -74.2 | -84.2 | -33.8 | -23.4 | -25.5 | -26.1 | -25,780.7 |
Net margin | -191.4% | -491.8% | -13876.6% | -5941.7% | -2969.6% | -8732.4% | | |
|
Diluted EPS | ($3.12) | ($42.93) | ($9,023.14) | ($6,442.75) | ($37.53) | ($298.97) | ($404.25) | ($7.03) |
Shares outstanding (diluted) | 6.9 | 1.7 | 0.0 | 0.0 | 0.6 | 0.1 | 0.1 | 3,667.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|